Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
presentation   published : Today    source : Www.globenewswire.com    save search
Pre-Investor Call Presentation available to shareholders
Published: 2024-04-25 (Crawled : 07:00) - globenewswire.com
ALSMY | News | $1.63 -1.78% 430K twitter stocktwits trandingview |
Manufacturing
 | Email alert Add to watchlist
AOMFF | News | $16.53 95.45% 25 twitter stocktwits trandingview |
Producer Manufacturing
 | Email alert Add to watchlist
JNJ | News | $148.53 -0.69% -0.14% 9.6M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
presentation
Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 21:00) - globenewswire.com
MURA | $3.595 -1.78% -1.81% 110K twitter stocktwits trandingview |
| Email alert Add to watchlist
presentation meeting
BioAtla Announces Upcoming Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
BCAB | $2.35 4.91% 4.68% 390K twitter stocktwits trandingview |
| Email alert Add to watchlist
presentation meeting
FreightCar America, Inc. to Present at Planet MicroCap Showcase: VEGAS 2024
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
RAIL 4 | $3.55 -1.7% 20K twitter stocktwits trandingview |
Producer Manufacturing
 | Email alert Add to watchlist
microcap
Erasca Announces Three Presentations at the 2024 ASCO Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
ERAS | $1.88 -2.59% -2.66% 530K twitter stocktwits trandingview |
| Email alert Add to watchlist
asco meeting
Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
BDTX | $5.05 0.8% 0.79% 360K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
meeting therapeutics
NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
NXTC | $1.43 -6.54% -6.99% 180K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
nc410 asco
IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
IOBT | $1.455 -1.02% -1.03% 57K twitter stocktwits trandingview |
| Email alert Add to watchlist
biotech presentation for meeting
Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
FRLN | $6.48 0.0% 0 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
disease cell meeting parkinson’s therapy
Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
KRON | $0.9644 1.52% 1.49% 880K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
kb-0742 update meeting trial
Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
CRBP | $35.5 -5.94% -6.37% 220K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
presentation asco pharmaceuticals for meeting
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
POAI | $1.34 3.88% 3.73% 24K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
presentation for meeting
Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
SNSE | $0.96 -3.78% -3.93% 55K twitter stocktwits trandingview |
| Email alert Add to watchlist
sns-101 asco topline meeting study
TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
TCRX | News 3 d | $7.39 1.79% 1.76% 91K twitter stocktwits trandingview |
Professional, Scientific, and T...
 | Email alert Add to watchlist
meeting therapeutics
SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 17:00) - globenewswire.com
SWTX | $43.37 -1.43% -1.45% 470K twitter stocktwits trandingview |
Health Technology
 | | O: -0.05% H: 2.16% C: -1.36%
presentation for meeting therapeutics
BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Selected for Presentation at 2024 ASCO Annual Meeting
Published: 2024-04-24 (Crawled : 14:00) - globenewswire.com
BTAI | News | $2.7 -9.09% -10.0% 880K twitter stocktwits trandingview |
Health Technology
 | | O: 0.0% H: 0.67% C: -8.75%
bxcl701 keytruda presentation asco pancreatic for meeting trial therapeutics
Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 14:00) - globenewswire.com
CUE | $1.43 -4.67% -4.9% 320K twitter stocktwits trandingview |
Health Technology
 | | O: 2.0% H: 3.27% C: -7.19%
cue biopharma meeting
Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the 2024 ASCO Annual Meeting
Published: 2024-04-24 (Crawled : 14:00) - globenewswire.com
MDNAF | $1.14 -17.54% 58K twitter stocktwits trandingview |
n/a
 | | O: 0.88% H: 21.74% C: 20.87%
mdna11 presentation asco meeting study
Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024
Published: 2024-04-24 (Crawled : 14:00) - globenewswire.com
CGEM | $18.9 13.38% 11.8% 1.2M twitter stocktwits trandingview |
| | O: 0.12% H: 17.14% C: 13.18%
cln-619 asco tumors therapeutics advanced study
Immunocore announces upcoming presentation and posters at ASCO 2024
Published: 2024-04-24 (Crawled : 14:00) - globenewswire.com
IMCR | $58.52 2.11% 2.07% 390K twitter stocktwits trandingview |
Manufacturing
 | | O: -0.1% H: 2.34% C: 2.13%
presentation asco
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services
BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services
WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services
AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services
MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information
RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance
Your saved searches
Save your searches and get alerts when important news are released.